what is the difference between gip and glp 1 dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)

PMID 3467353

Zepbound (tirzepatide): Manufactured by Eli Lilly and FDA-approved for chronic weight management, Zepbound contains the same active ingredient as Mounjaro and has been referenced in current GLP-1 litigation

CDC Injection Safety Preventing Unsafe Injection Practices

Tirzepatide treatment was also associated with a reduction in waist circumference, systolic blood pressure, fasting insulin and plasma lipid concentrations as cardiometabolic risk parameters

- Use unknown for qualitative statuses only when the note mentions the domain but does not make the polarity clear

They can be especially problematic for people with diverticulitis because of the vitamins effects on the GI system